This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Yi Y, Verdian L, Jansen JP.Rufinamide in the adjunctive treatment of Lennox-Gastaut syndrome: a cost effectiveness analysis. 11th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research: 605 abstr. PND18, 8 Nov 2008
Rights and permissions
About this article
Cite this article
Rufinamide another option in LGS. Pharmacoecon. Outcomes News 567, 3 (2008). https://doi.org/10.2165/00151234-200805670-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805670-00002